ALPHAEON Closes Acquisition of LENSAR

Dec 17, 2015, 06:00 ET from ALPHAEON Corporation

IRVINE, Calif., Dec. 17, 2015 /PRNewswire/ -- ALPHAEON Corporation, a social commerce company and subsidiary to Strathspey Crown Holdings LLC, today announced it has closed on its acquisition of LENSAR, Inc., a leading global developer and manufacturer of Femtosecond Lasers Systems (FLS), through a wholly owned subsidiary. Terms of the acquisition were not disclosed.

The LENSAR® Laser System was designed for patients seeking a premium vision outcome following the removal of their crystalline lens. With this announcement, ALPHAEON has expanded its global ophthalmology business, and has enabled the company to provide advanced technology to its broad network of more than 4,200 board-certified ophthalmologists globally.

"We are pleased to have closed the acquisition of LENSAR," said Robert E. Grant, CEO of ALPHAEON. "The advancements they have made in the self-pay category of precision refractive surgery complement our lifestyle product portfolio, allowing ophthalmologists to offer another alternative to patients."

About LENSAR, Inc.
LENSAR, Inc. is a commercial stage medical device company providing Femtosecond Laser technology for cataract treatment.  Founded in 2004 and based in Orlando, FL, LENSAR developed the first femtosecond cataract laser to enable automation of several critical surgical procedure planning and delivering elements.  For more information, visit

About ALPHAEON Corporation
ALPHAEON Corporation is a social commerce company with the goal of transforming self-pay healthcare by bringing to market highly innovative products and services to promote consumer wellness, beauty and performance. The company works in partnership with board certified physicians ensuring access to leading advancements in lifestyle healthcare. For more information, please visit

Jenna Mons Senior Vice President of Marketing and Communications
Tel: +1-904-343-3449

Ashwin Agarwal Vice President of Investor Relations and Finance
Tel: +1-949-284-4730